Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.

Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston Salem, NC, USA Department of Pharmacology, University of Toronto, Toronto, Canada.
Addiction Biology (Impact Factor: 5.91). 03/2012; DOI: 10.1111/j.1369-1600.2012.00456.x
Source: PubMed

ABSTRACT Methylphenidate (MPH) is a commonly abused psychostimulant prescribed for the treatment of attention deficit hyperactivity disorder. MPH has a mechanism of action similar to cocaine (COC) and is commonly characterized as a dopamine transporter (DAT) blocker. While there has been extensive work aimed at understanding dopamine (DA) nerve terminal changes following COC self-administration, very little is known about the effects of MPH self-administration on the DA system. We used fast scan cyclic voltammetry in nucleus accumbens core slices from animals with a 5-day self-administration history of 40 injections/day of either MPH (0.56 mg/kg) or COC (1.5 mg/kg) to explore alterations in baseline DA release and uptake kinetics as well as alterations in the interaction of each compound with the DAT. Although MPH and COC have similar behavioral effects, the consequences of self-administration on DA system parameters were found to be divergent. We show that COC self-administration reduced DAT levels and maximal rates of DA uptake, as well as reducing electrically stimulated release, suggesting decreased DA terminal function. In contrast, MPH self-administration increased DAT levels, DA uptake rates and DA release, suggesting enhanced terminal function, which was supported by findings of increased metabolite/DA tissue content ratios. Tyrosine hydroxylase messenger RNA, protein and phosphorylation levels were also assessed in both groups. Additionally, COC self-administration reduced COC-induced DAT inhibition, while MPH self-administration increased MPH-induced DAT inhibition, suggesting opposite pharmacodynamic effects of these two drugs. These findings suggest that the factors governing DA system adaptations are more complicated than simple DA uptake blockade.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous literature investigating neurobiological adaptations following cocaine self-administration has shown that the development of pharmacodynamic tolerance, characterized by reduced cocaine potency at the dopamine transporter (DAT), results from high, continuous levels of intake (long-access; LgA), while sensitization of cocaine potency is caused by intermittent patterns of cocaine administration (intermittent-access; IntA). Here we aimed to determine if the changes observed following cocaine self-administration were specific to cocaine, or translated to other psychostimulants as well. Potency was assessed by fast scan cyclic voltammetry in brain slices containing the nucleus accumbens following control, IntA, short-access (ShA), and LgA. We assessed the potency of amphetamine, a releaser, and methylphenidate (MPH), a DAT blocker that is functionally similar to cocaine and structurally related to amphetamine. Changes in MPH potency can give information as to the importance of functional or structural aspects of compounds as related to the expression of tolerance/sensitization effects. MPH and amphetamine potencies were increased following IntA, while neither was changed following LgA. Here we demonstrate that while LgA-induced tolerance at the DAT is specific to cocaine, the sensitizing effects of IntA are conferred to cocaine, MPH, and amphetamine. The unchanged potency of MPH following LgA suggests that the expression of tolerance does not rely on the function of the compound as blocker/releaser. This demonstrates that the pattern with which cocaine is administered is important in determining the neurochemical consequences of not only cocaine effects, but cross-sensitization/cross-tolerance effects of other psychostimulants as well.
    Journal of Pharmacology and Experimental Therapeutics 02/2014; · 3.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Long-access methylphenidate (MPH) self-administration has been shown to produce enhanced amphetamine potency at the dopamine transporter and concomitant changes in reinforcing efficacy, suggesting that MPH abuse may change the dopamine system in a way that promotes future drug abuse. While long-access self-administration paradigms have translational validity for cocaine, it may not be as relevant a model of MPH abuse, as it has been suggested that people often take MPH intermittently. Although previous work outlined the neurochemical and behavioral consequences of long-access MPH self-administration, it was not clear whether intermittent access (6 h session; 5min access/30min) would result in similar changes. For cocaine, long-access self-administration resulted in tolerance to cocaine's effects on dopamine and behavior while intermittent-access resulted in sensitization. Here we assessed the neurochemical consequences of intermittent-access MPH self-administration on dopamine terminal function. We found increased maximal rates of uptake, increased stimulated release, and subsensitive D2-like autoreceptors. Consistent with previous work using extended-access MPH paradigms, the potencies of amphetamine and MPH, but not cocaine, were increased, demonstrating that unlike cocaine, MPH effects were not altered by the pattern of intake. Although the potency results suggest that MPH may share properties with releasers, dopamine release was increased following acute application of MPH, similar to cocaine, and in contrast to the release decreasing effects of amphetamine. Taken together, these data demonstrate that MPH exhibits properties of both blockers and releasers, and that the compensatory changes produced by MPH self-administration may increase the abuse liability of amphetamines, independent of the pattern of administration.
    Neuropharmacology 03/2014; · 4.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Drug addiction is a neuropsychiatric disorder marked by escalating drug use. Dopamine neurotransmission in the ventromedial striatum (VMS) mediates acute reinforcing effects of abused drugs, but with protracted use the dorsolateral striatum is thought to assume control over drug seeking. We measured striatal dopamine release during a cocaine self-administration regimen that produced escalation of drug taking in rats. Surprisingly, we found that phasic dopamine decreased in both regions as the rate of cocaine intake increased, with the decrement in dopamine in the VMS significantly correlated with the rate of escalation. Administration of the dopamine precursor L-DOPA at a dose that replenished dopamine signaling in the VMS reversed escalation, thereby demonstrating a causal relationship between diminished dopamine transmission and excessive drug use. Together these data provide mechanistic and therapeutic insight into the excessive drug intake that emerges following protracted use.
    Nature Neuroscience 04/2014; · 15.25 Impact Factor


Available from
Nov 23, 2014